Empagliflozin Monotherapy in Japanese Patients with Type 2 Diabetes Mellitus: a Randomized, 12-Week, Double-Blind, Placebo-Controlled, Phase II Trial
Crossref DOI link: https://doi.org/10.1007/s12325-014-0126-8
Published Online: 2014-06-24
Published Print: 2014-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kadowaki, Takashi
Haneda, Masakazu
Inagaki, Nobuya
Terauchi, Yasuo
Taniguchi, Atsushi
Koiwai, Kazuki
Rattunde, Henning
Woerle, Hans J.
Broedl, Uli C.
Text and Data Mining valid from 2014-06-01